跳至主要内容
临床试验/NCT01905904
NCT01905904已完成4 期

The Comparision of Different Doses of Sevoflurane for Induction of General Anesthesia in Electroconvulsive Therapy

Inonu University1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2013年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
25
试验地点
1
主要终点
sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure

研究概览

简要总结

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

详细描述

Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia

排除标准

  • Pregnancy
  • Cerebrovascular disease
  • Unstable cardiovascular disease
  • Chronic obstructive pulmonary disease; and
  • Renal or hepatic failure

研究组 & 干预措施

sevorane

Active Comparator

Sevorane 4% concentration during anesthesia induction

干预措施: sevorane (Drug)

sevorane %7

Active Comparator

Sevorane 7% concentration during anesthesia induction

干预措施: sevorane (Drug)

结局指标

主要结局

sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure

时间窗: taken prior to the seizure

次要结局

  • sevoflurane used in electroconvulsive therapy (ECT) on hemodynamic response.(taken prior to the seizure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ülkü Özgül

assistant profesor

Inonu University

研究点 (1)

Loading locations...

相似试验